150 related articles for article (PubMed ID: 10068570)
1. The molecular epidemiology and evolution of Epstein-Barr virus: sequence variation and genetic recombination in the latent membrane protein-1 gene.
Walling DM; Shebib N; Weaver SC; Nichols CM; Flaitz CM; Webster-Cyriaque J
J Infect Dis; 1999 Apr; 179(4):763-74. PubMed ID: 10068570
[TBL] [Abstract][Full Text] [Related]
2. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene.
Correa RM; Fellner MD; Alonio LV; Durand K; Teyssié AR; Picconi MA
J Med Virol; 2004 Aug; 73(4):583-8. PubMed ID: 15221903
[TBL] [Abstract][Full Text] [Related]
3. Sequence variation in the Epstein-Barr virus latent membrane protein 1.
Miller WE; Edwards RH; Walling DM; Raab-Traub N
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2729-40. PubMed ID: 7931159
[TBL] [Abstract][Full Text] [Related]
4. Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains.
Edwards RH; Seillier-Moiseiwitsch F; Raab-Traub N
Virology; 1999 Aug; 261(1):79-95. PubMed ID: 10441557
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes.
Görzer I; Niesters HG; Cornelissen JJ; Puchhammer-Stöckl E
Virus Res; 2006 Jun; 118(1-2):105-14. PubMed ID: 16406167
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
7. Frequency of a 30-base pair deletion in the latent membrane protein-1 gene in Epstein-Barr virus-associated lymphomas in Japan.
Hirose Y; Masaki Y; Kurose N
Int J Hematol; 2000 Aug; 72(2):210-5. PubMed ID: 11039671
[TBL] [Abstract][Full Text] [Related]
8. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
9. Widespread sequence variation in the Epstein-Barr virus latent membrane protein 2A gene among northern Chinese isolates.
Wang X; Liu X; Jia Y; Chao Y; Xing X; Wang Y; Luo B
J Gen Virol; 2010 Oct; 91(Pt 10):2564-73. PubMed ID: 20554797
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.
Fielding CA; Sandvej K; Mehl A; Brennan P; Jones M; Rowe M
J Virol; 2001 Oct; 75(19):9129-41. PubMed ID: 11533177
[TBL] [Abstract][Full Text] [Related]
11. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection.
Shibata Y; Hoshino Y; Hara S; Yagasaki H; Kojima S; Nishiyama Y; Morishima T; Kimura H
J Med Virol; 2006 Jun; 78(6):770-9. PubMed ID: 16628581
[TBL] [Abstract][Full Text] [Related]
12. The truncated form of the Epstein-Barr virus LMP-1 is dispensable or complimentable by the full-length form in virus infection and replication.
Torii T; Konishi K; Sample J; Takada K
Virology; 1998 Nov; 251(2):273-8. PubMed ID: 9837791
[TBL] [Abstract][Full Text] [Related]
13. [Sequence analysis of the carboxy terminal of the Epstein-Barr virus LMP-1 oncogene in Epstein-Barr virus associated disorders].
Itakura O; Kikuta H
Nihon Rinsho; 1997 Feb; 55(2):467-72. PubMed ID: 9046842
[TBL] [Abstract][Full Text] [Related]
14. [Construction of three transgenic vectors carrying the latent membrane protein gene of Epstein-Barr virus].
Xiao Z; Guan Y; Duan C; Chen Z; Yao K
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):1-4. PubMed ID: 11938726
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus genotypes in multiple sclerosis.
Lindsey JW; Patel S; Zou J
Acta Neurol Scand; 2008 Feb; 117(2):141-4. PubMed ID: 18184350
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of a 30-base pair deletion and single-base mutations within the carboxy terminal end of the LMP-1 oncogene of Epstein-Barr virus in the Japanese population.
Itakura O; Yamada S; Narita M; Kikuta H
Oncogene; 1996 Oct; 13(7):1549-53. PubMed ID: 8875994
[TBL] [Abstract][Full Text] [Related]
17. Molecular markers of clonality and identity in Epstein-Barr virus-associated B-cell lymphoproliferative disease.
Walling DM; Andritsos LA; Etienne W; Payne DA; Aronson JF; Flaitz CM; Nichols CM
J Med Virol; 2004 Sep; 74(1):94-101. PubMed ID: 15258974
[TBL] [Abstract][Full Text] [Related]
18. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
19. Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity.
Saechan V; Mori A; Mitarnun W; Settheetham-Ishida W; Ishida T
J Clin Virol; 2006 Jun; 36(2):119-25. PubMed ID: 16616610
[TBL] [Abstract][Full Text] [Related]
20. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]